Common Contracts
2 similar License Agreement contracts by Oncternal Therapeutics, Inc.
AMENDMENT NO. 3 TO THE AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 12th, 2021 • Oncternal Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 3 (“Amendment No.3”) is made as of the Amendment No. 3 Effective Date by and between Oncternal Therapeutics, Inc. having an address at 12230 El Camino Real, Suite 300, San Diego, California 92130 ("LICENSEE") and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), represented by its San Diego campus having an address at University of California San Diego, Office of Innovation and Commercialization (“OIC”), Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UC San Diego”).
AMENDMENT NO. 3 TO THE AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 11th, 2021 • Oncternal Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 3 (“Amendment No.3”) is made as of the Amendment No. 3 Effective Date by and between Oncternal Therapeutics, Inc. having an address at 12230 El Camino Real, Suite 300, San Diego, California 92130 ("LICENSEE") and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), represented by its San Diego campus having an address at University of California San Diego, Office of Innovation and Commercialization (“OIC”), Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UC San Diego”).
